Announcements Trials

Browse Landscape

Status

Completed 31 Active not recruiting 15 Recruiting 14 Terminated 11 Unknown 4 Withdrawn 2 No longer available 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Primary Myelofibrosis 1 Polycythemia Vera 1

Interventions

selinexor 1 ruxolitinib 1 asciminib 1 Imatinib Mesylate 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × ruxolitinib × Myeloid × Clear all

NCT04745637 2025-11-18

Managed Access Programs for INC424, Ruxolitinib

Novartis

Polycythemia Vera, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡